Live Journal Club
On December 6, 2022, the TER coordinators Allison Mo, Susan Brunskill and Catherine Kimber held a Live Journal Club where they invited the reviewers to discuss selected papers from the Round-Up.
Welcome to the quarterly Transfusion Evidence Round-Up.
This is a collaboration between the International Society of Blood Transfusion (ISBT) and the Transfusion Evidence Library (TEL). We aim to highlight high quality evidence randomised controlled trials and systematic reviews about an internationally relevant subject in the field of Transfusion Medicine. All references are drawn from the Transfusion Evidence Library and, where relevant, Stem Cell Evidence.
This Transfusion Evidence Round-Up is sent to ISBT members and TEL subscribers, so if you are a subscriber to both mailing lists and receive it twice please bear with us until we can resolve this.
The Transfusion Evidence Library is produced by the Systematic Review Initiative (SRI) and funded by the four UK blood services. It is available free at the point of access providing a comprehensive and up-to-date database of high quality evidence in Transfusion Medicine.
Top 10 articles
Like always in the Round-Ups, 10 articles were selected from the Transfusion Evidence Library by 3 reviewers: Samclide Mbikayi, Rebecca Griffith and Aikaj Jindal.
Red blood cell transfusion in myelodysplastic syndromes: A systematic review. Kaka, S., et al. (2021). Transfusion Medicine.
These articles were discussed during the Live Journal Club.
Red blood cell transfusion in myelodysplastic syndromes: A systematic review.
Kaka, S., et al. (2021). Transfusion Medicine.
Transfusion thresholds for guiding red blood cell transfusion.
Carson, J.L., et al. (2021). The Cochrane Database of Systematic Reviews.
Effect of washed versus unwashed red blood cells on transfusion-related immune responses in preterm newborns.
Crawford, T.M., et al. (2022). Clinical & Translational Immunology.
Tranexamic Acid in Patients Undergoing Noncardiac Surgery.
Devereaux, P.J., et al. (2022). The New England Journal of Medicine.
Economic evaluation of Restrictive Vs. Liberal Transfusion Strategy Following Acute Myocardial Infarction (REALITY): trial-based cost effectiveness and cost utility analyses.
Durand-Zaleski, I., et al. (2022). European Heart Journal. Quality of Care & Clinical Outcomes.
Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
Fasano, R.M., et al. (2018). Transfusion Medicine Reviews.
Serum or plasma ferritin concentration as an index of iron deficiency and overload.
Garcia-Casal, M.N., et al. (2021). The Cochrane Database of Systematic Reviews.
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia: A Randomized Clinical Trial.
Menichetti, F., et al. (2021). JAMA Network Open.
Effects of Freshly Irradiated vs Irradiated and Stored Red Blood Cell Transfusion on Cerebral Oxygenation in Preterm Infants: A Randomized Clinical Trial.
Saito-Benz, M., et al. (2022). JAMA Pediatrics.
Hyperkalaemia Following Blood Transfusion-a Systematic Review Assessing Evidence and Risks.
Wolf, J., et al. (2022). Transfusion Medicine Reviews.
Systematic Research Initiative
The Systematic Review Initiative (SRI) is a clinical research group established in 2001 by NHS Blood and Transplant (NHSBT) and funded by the UK Blood Services. The primary objective of the SRI is to “develop the evidence base for the practice of transfusion medicine”, by undertaking systematic reviews and other evidence-based medicine research projects in the transfusion field. @sritransfusion
Transfusion Evidence Library
Stem Cell Evidence
Stem Cell Evidence is a comprehensive collection of high quality research relevant to haematopoietic stem cell transplantation, updated monthly. The most important articles in the field are highlighted in the Stem Cell Evidence Alert which is a newsletter emailed to subscribers. Stem Cell Evidence aims to be a key resource worldwide for medical practitioners, clinical researchers and policy makers. It is also intended to be of value to those planning new clinical trials in the field. It is produced by the Systematic Review Initiative and funded by the UK Blood Services and Oxford Biomedical Research Centre.